Skip to content
PICO Portalanswers from OpenAlex

Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis

PaperCitations, authors & open-access status

Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis is a paper indexed in PICO Portal from OpenAlex.

How many citations does Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis have?

PICO Portalcitation count

Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis has 18 citations in the OpenAlex counts PICO Portal stores.

When was Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis published?

PICO Portalyear

Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis has 2021 year in the PICO Portal index.

What is the open-access status of Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis?

PICO Portaloa status

Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis has closed oa status in the PICO Portal index.

What is the DOI of Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis?

PICO Portaldoi

The DOI for Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis is on the source record.

What is the PMID of Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis?

PICO Portalpmid

The PMID for Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis is on the source record.

What is the OpenAlex record for Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis?

PICO Portalopenalex

The OpenAlex for Treatment and Prognosis of Hepatic Epithelioid Hemangioendothelioma: A SEER Database Analysis is on the source record.

Related on PICO Portal

470M+ articles · 14-day free trial